EGFR and adenocarcinoma: For instance, East Asian lung cancer patients, predominantly non-smokers with adenocarcinoma, have a much higher prevalence of epidermal growth factor receptor (EGFR) mutation than their Western counterparts (~30% and 7%, respectively)10.